Bernstein reiterates StandardAero stock rating on strong demand By Investing.com

StandardAero reported Q1 2026 revenue of $1.63 billion, up 13.3% organically year over year, with adjusted EPS of $0.33 meeting expectations. Bernstein reiterated an Outperform rating and $39 price target, citing strong demand, 20% growth in business jet activity, and 11%/10% growth in commercial aerospace and defense revenues, though margins were pressured by facility ramp-up and inventory burndown. The stock traded lower after hours despite the solid operating update.

Analysis

SARO’s setup is less about the quarter itself and more about the earnings power inflection once the new engine lines move from drag to leverage. The near-term margin pressure from ramp costs and mix shift looks mechanical, while capacity being effectively sold out on key programs suggests revenue can keep compounding even if the macro cools. That combination usually matters most for industrial MRO names because the market tends to underwrite the current margin, not the forward margin pool.

The second-order winner is the broader aerospace aftermarket ecosystem: OEM-aligned service providers, component repair shops, and niche test/inspection vendors should all see tighter utilization and better pricing power if shop visit demand stays above supply. The likely loser is any competitor still earlier in its capacity ramp, because SARO’s scale can absorb temporary under-earning and then re-rate faster once the fixed-cost base is loaded. Defense exposure also provides a partial hedge versus commercial cyclicality, which reduces the probability of a sudden multiple de-rating.

The key risk is timing. If airline profitability deteriorates more sharply over the next 2-3 quarters, customers could delay discretionary work, even if engine hours remain high; that would mainly hit mix and timing rather than the longer-term shop-visit thesis. The market’s negative after-hours reaction looks more like skepticism toward near-term margin visibility than a rejection of the longer-duration thesis, which creates a window for patient positioning.

Consensus may be missing that the runway for margin expansion is not just operational maturity but also commercial terms: shifting away from low-margin pass-throughs should structurally improve quality of earnings. If that transition persists, reported revenue growth will likely understate true earnings leverage over the next 12-24 months. The valuation gap looks especially attractive if management can show even modest sequential margin recovery before year-end.

Key Decisions for Investors

• Long SARO on weakness over the next 1-2 weeks; target a 12-18 month hold into margin maturation, with upside tied to visible gross margin inflection and downside limited to temporary ramp noise.
• Use a staged entry: buy one-third now, one-third after the next quarterly print, and reserve one-third for any pullback tied to macro selloffs; this reduces timing risk around capacity-ramp execution.
• Pair trade: long SARO / short a lower-quality aerospace MRO peer with less installed capacity and weaker defense mix; thesis is that SARO should earn a premium as utilization stays tight and mix improves.
• For higher-risk accounts, buy SARO Jan-2027 calls or call spreads to express the 18-24 month margin expansion view with defined downside, since the market is likely underappreciating operating leverage.
• Set a tactical stop if gross margin fails to improve sequentially over the next two quarters; that would indicate the ramp is taking longer than expected and could cap multiple expansion.